DePuy Synthes, a subsidiary of Johnson & Johnson, is a multinational medical device company headquartered in Zuchwil, Switzerland. The company is focused on providing innovative solutions for orthopedic and neurological procedures, with a strong emphasis on improving patient outcomes and healthcare system efficiency. DePuy Synthes has a rich history that dates back more than a century.

It was founded in 1895 by Revra DePuy and started as a small orthopedic appliance company in Indiana, USA. In 1998, DePuy merged with Synthes, a Swiss orthopedic company founded in 1956, to create DePuy Synthes. This combination brought together two industry leaders and expanded the company's product offerings and geographical presence.

The company's headquarters are located in Zuchwil, Switzerland. This facility serves as the central hub for research and development, manufacturing, sales, and administration. Additionally, DePuy Synthes has a significant presence in the United States, with sites in Pennsylvania, Massachusetts, and California, among others.

DePuy Synthes offers a wide range of products and services to address various orthopedic and neurological conditions. These include joint replacements, trauma implants, spinal devices, sports medicine solutions, and neurovascular products. The company's portfolio features innovative technologies that aim to improve surgical techniques, enhance patient recovery, and reduce healthcare costs.

On a global scale, DePuy Synthes has established numerous subsidiaries, joint ventures, and partnerships. Notably, the company has collaborations with academic institutions, healthcare professionals, and research organizations to foster innovation and develop cutting-edge solutions. Some of its notable joint ventures include Bioventus, a global leader in orthobiologic solutions, and Fidia Pharma, a leading Italian pharmaceutical company.

DePuy Synthes is a market leader in the orthopedic and neurological device industry. It enjoys a strong market position globally, with significant sales across various regions. The company's commitment to research and development, along with strategic acquisitions and partnerships, has played a crucial role in maintaining its competitive edge.

The company has achieved several milestones and made notable changes to its strategy over the years. For example, in 2012, DePuy Synthes launched the ATTUNE Knee System, an advanced implant designed to enhance stability and motion in knee replacements. This marked a significant advancement in knee arthroplasty technology.

Currently, DePuy Synthes continues to innovate and evolve its product lineup to meet the evolving needs of patients and healthcare providers. While specific latest updates or key information are not available, the company's strong reputation and commitment to excellence position it well for continued growth and success in the global medical device market